CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment)

Sponsor
Hôpital Edouard Herriot (Other)
Overall Status
Completed
CT.gov ID
NCT03455595
Collaborator
(none)
60
1
12
5

Study Details

Study Description

Brief Summary

Prospective study so as to evaluate CONECCT score to determine both histological tissue and therapeutic choice

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic exams

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
CONECCT Score so as to Improve the Diagnosis and the Treatment of Colorectal Neoplasia
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Feb 1, 2018
Actual Study Completion Date :
Feb 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Evaluation of the CONECCT endoscopic score so as to improve colon therapeutic treatment polyps [one year]

    There are recognized diagnostic criteria so as to predict the histology of colorectal lesions and thus to choose the right therapy. For the moment, these criteria are scattered in at least 5 different classifications and the CONECCT tool will allow gastroenterology interns to more easily predict the histology of the lesion and so to improve the management of them.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • N/A
Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 Edouard Herriot Hospital Lyon Rhône Alpes France 69437

Sponsors and Collaborators

  • Hôpital Edouard Herriot

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jean Christophe Saurin, Professor, Hôpital Edouard Herriot
ClinicalTrials.gov Identifier:
NCT03455595
Other Study ID Numbers:
  • CONECCT
First Posted:
Mar 6, 2018
Last Update Posted:
Mar 12, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 12, 2018